UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Arcutis Biotherapeutics
ARQT
$3.22B
| $2.57M | ﹤0.01% |
276,691
+2,912
| +1% | +$28.7K |
|
|
MTTR
1902
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $2.55M | ﹤0.01% |
567,078
-58,082
| -9% | -$253K |
|
1903
Innoviva
INVA
$1.48B
| $2.54M | ﹤0.01% |
131,449
-22,961
| -15% | -$423K |
|
1904
Caleres
CAL
$489M
| $2.53M | ﹤0.01% |
76,646
-421
| -0.5% | -$15.3K |
|
1905
Navient
NAVI
$837M
| $2.53M | ﹤0.01% |
162,069
-12,816
| -7% | -$197K |
|
1906
Agilon Health
AGL
$1.7B
| $2.52M | ﹤0.01% |
25,602
+1,509
| +6% | +$195K |
|
1907
Liberty Broadband Class A
LBRDA
$5.09B
| $2.51M | ﹤0.01% |
32,611
-13,673
| -30% | -$832K |
|
1908
Liberty Latin America Class C
LILAK
$1.62B
| $2.5M | ﹤0.01% |
290,082
-37,168
| -11% | -$326K |
|
1909
Supernus Pharmaceuticals
SUPN
$2.77B
| $2.5M | ﹤0.01% |
80,196
-12,343
| -13% | -$385K |
|
1910
CRA International
CRAI
$1.07B
| $2.49M | ﹤0.01% |
14,192
-1,999
| -12% | -$334K |
|
|
PMT
1911
PennyMac Mortgage Investment
PMT
$821M
| $2.49M | ﹤0.01% |
174,436
+82,735
| +90% | +$1.15M |
|
1912
Marcus & Millichap
MMI
$1.19B
| $2.48M | ﹤0.01% |
62,522
+1,120
| +2% | +$42.3K |
|
1913
Mirum Pharmaceuticals
MIRM
$6.1B
| $2.47M | ﹤0.01% |
63,461
+3,442
| +6% | +$137K |
|
1914
Harmony Biosciences
HRMY
$2.27B
| $2.47M | ﹤0.01% |
61,653
-6,719
| -10% | -$236K |
|
1915
Napco Security Technologies
NSSC
$1.46B
| $2.47M | ﹤0.01% |
60,936
-12,053
| -17% | -$591K |
|
1916
Bloomin' Brands
BLMN
$958M
| $2.46M | ﹤0.01% |
148,931
-417,348
| -74% | -$7.4M |
|
|
ARCH
1917
DELISTED
Arch Resources, Inc.
ARCH
| $2.46M | ﹤0.01% |
17,798
-2,039
| -10% | -$281K |
|
1918
Vaalco Energy
EGY
$600M
| $2.46M | ﹤0.01% |
428,325
-31,100
| -7% | -$196K |
|
|
ODP
1919
DELISTED
ODP
ODP
| $2.46M | ﹤0.01% |
82,606
+790
| +1% | +$26.3K |
|
1920
ICICI Bank
IBN
$107B
| $2.45M | ﹤0.01% |
82,216
+26,025
| +46% | +$757K |
|
1921
IonQ
IONQ
$15.9B
| $2.45M | ﹤0.01% |
280,104
-26,660
| -9% | -$203K |
|
1922
CoreCivic
CXW
$3.39B
| $2.45M | ﹤0.01% |
193,459
+62,022
| +47% | +$827K |
|
1923
Life Time Group Holdings
LTH
$9.64B
| $2.45M | ﹤0.01% |
100,212
-5,785
| -5% | -$130K |
|
1924
SiriusPoint
SPNT
$2.66B
| $2.44M | ﹤0.01% |
169,934
-28,432
| -14% | -$398K |
|
1925
Utz Brands
UTZ
$1.25B
| $2.43M | ﹤0.01% |
137,460
-15,484
| -10% | -$257K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.